Synapse

← Charles M. Perou

Papers by Charles M. Perou

Page 9 · newest first

  1. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI Journal of the National Cancer Institute · 2009
  2. Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell CharacteristicsCancer Research · 2009
  3. PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast CancerCancer Research · 2009
  4. A compact VEGF signature associated with distant metastases and poor outcomesBMC Medicine · 2009
  5. Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology · 2009
  6. Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 TrialJournal of Clinical Oncology · 2009
  7. Microarrays and Epidemiology: Ensuring the Impact and Accessibility of Research FindingsCancer Epidemiology Biomarkers & Prevention · 2009
  8. Triple-Negative Breast Cancer: Risk Factors to Potential TargetsClinical Cancer Research · 2008
  9. The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomasBreast Cancer Research · 2008
  10. A supervised risk predictor of breast cancer based on biological subtypesJournal of Clinical Oncology · 2008
  11. Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1Molecular Cancer · 2008
  12. A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profilingBritish Journal of Cancer · 2008
  13. High-throughput amplicon scanning of the TP53 gene in breast cancer using high-resolution fluorescent melting curve analyses and automatic mutation callingHuman Mutation · 2008
  14. Merging two gene-expression studies via cross-platform normalizationBioinformatics · 2008
  15. Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative PhenotypeClinical Cancer Research · 2008
  16. Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer EvolutionClinical Cancer Research · 2008
  17. Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and ConquerCancer Investigation · 2008
  18. Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosisPROTEOMICS - CLINICAL APPLICATIONS · 2007
  19. Common Genetic Variation in GATA-Binding Protein 3 and Differential Susceptibility to Breast Cancer by Estrogen Receptor α Tumor StatusCancer Epidemiology Biomarkers & Prevention · 2007
  20. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancerInternational Journal of Cancer · 2007
  21. FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and SurvivalClinical Cancer Research · 2007
  22. EGFR associated expression profiles vary with breast tumor subtypeBMC Genomics · 2007
  23. Clustering microarray-derived gene lists through implicit literature relationshipsBioinformatics · 2007
  24. Agreement in Breast Cancer Classification between Microarray and Quantitative Reverse Transcription PCR from Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded TissuesClinical Chemistry · 2007
  25. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumorsGenome biology · 2007
  26. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research · 2007
  27. Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomasBreast Cancer Research · 2007
  28. A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple MalignanciesPLoS Medicine · 2006
  29. Gene expression patterns associated with p53 status in breast cancerBMC Cancer · 2006
  30. Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancerMolecular Cancer Therapeutics · 2006
  31. Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient CohortsJournal of Clinical Oncology · 2006
  32. Cytokeratin profiles of male breast cancersHistopathology · 2006
  33. Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine · 2006
  34. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA · 2006
  35. The molecular portraits of breast tumors are conserved across microarray platformsBMC Genomics · 2006
  36. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assayThe Medicine Forum · 2006
  37. Gene Expression Profile Signatures Indicate a Role for Wnt Signaling in Endothelial Commitment From Embryonic Stem CellsCirculation Research · 2006
  38. Evaluating the comparability of gene expression in blood and brainAmerican Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2006
  39. Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast CancersJournal of Clinical Oncology · 2006
  40. siRNA: A Potential Tool for Future Breast Cancer Therapy?Critical Reviews™ in Oncogenesis · 2006
  41. Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast CancerCancer Research · 2005
  42. Breast Cancer Molecular Subtypes Respond Differently to Preoperative ChemotherapyClinical Cancer Research · 2005
  43. High Reproducibility using Sodium Hydroxide-Stripped Long Oligonucleotide DNA MicroarraysBioTechniques · 2005
  44. Prediction of Toxicant-Specific Gene Expression Signatures after Chemotherapeutic Treatment of Breast Cell LinesEnvironmental Health Perspectives · 2004
  45. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research · 2004
  46. Statistical modeling for selecting housekeeper genesGenome biology · 2004
  47. “Intrinsic Gene Expression” subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal-like tumors among black women of African ancestryJournal of Clinical Oncology · 2004
  48. “Intrinsic Gene Expression” subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal-like tumors among black women of African ancestryJournal of Clinical Oncology · 2004
  49. Race and the poor prognosis basal breast tumor (BBT) phenotype in the population-based Carolina Breast Cancer Study (CBCS)Journal of Clinical Oncology · 2004
  50. Race and the poor prognosis basal breast tumor (BBT) phenotype in the population-based Carolina Breast Cancer Study (CBCS)Journal of Clinical Oncology · 2004